{"id":"https://openalex.org/W4362489104","doi":"https://doi.org/10.1158/1535-7163.22521682","title":"Supplementary Data from Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFRY1068 Phosphorylation","display_name":"Supplementary Data from Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFRY1068 Phosphorylation","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362489104","doi":"https://doi.org/10.1158/1535-7163.22521682"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22521682","doi":"https://doi.org/10.1158/1535-7163.22521682","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22521682","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Depatuxizumab_Mafodotin_ABT-414_-induced_Glioblastoma_Cell_Death_Requires_EGFR_Overexpression_but_not_EGFR_sup_Y1068_sup_Phosphorylation/22521682/1/files/39984328.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Depatuxizumab_Mafodotin_ABT-414_-induced_Glioblastoma_Cell_Death_Requires_EGFR_Overexpression_but_not_EGFR_sup_Y1068_sup_Phosphorylation/22521682/1/files/39984328.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062595689","display_name":"Caroline von Achenbach","orcid":"https://orcid.org/0000-0002-6788-5259","observed_orcids":["https://orcid.org/0000-0002-6788-5259"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline von Achenbach","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001849164","display_name":"Manuela Silginer","orcid":"https://orcid.org/0000-0003-2538-1244","observed_orcids":["https://orcid.org/0000-0003-2538-1244"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manuela Silginer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031973170","display_name":"Vincent Blot","orcid":"https://orcid.org/0009-0003-4429-512X","observed_orcids":["https://orcid.org/0009-0003-4429-512X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vincent Blot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073603294","display_name":"William A. Weiss","orcid":"https://orcid.org/0000-0003-2230-9132","observed_orcids":["https://orcid.org/0000-0003-2230-9132"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William A. Weiss","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2230-9132","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5017177249","display_name":"Michael Weller","orcid":"https://orcid.org/0000-0002-1748-174X","observed_orcids":["https://orcid.org/0000-0002-1748-174X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Weller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9580000042915344,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9580000042915344,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abt-414","display_name":"ABT-414","score":0.9729999899864197},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/egfr-overexpression","display_name":"EGFR overexpression","score":0.949999988079071},{"id":"https://openalex.org/keywords/cell-death","display_name":"cell death","score":0.671999990940094},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.6779999732971191},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5640000104904175}],"concepts":[{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.7586779594421387},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.7141185998916626},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.623464822769165},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.488343209028244},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22817516326904297},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11659279465675354}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.22521682","doi":"https://doi.org/10.1158/1535-7163.22521682","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22521682","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Depatuxizumab_Mafodotin_ABT-414_-induced_Glioblastoma_Cell_Death_Requires_EGFR_Overexpression_but_not_EGFR_sup_Y1068_sup_Phosphorylation/22521682/1/files/39984328.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22521682","doi":"https://doi.org/10.1158/1535-7163.22521682","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22521682","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Data_from_Depatuxizumab_Mafodotin_ABT-414_-induced_Glioblastoma_Cell_Death_Requires_EGFR_Overexpression_but_not_EGFR_sup_Y1068_sup_Phosphorylation/22521682/1/files/39984328.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362489104.pdf","grobid_xml":"https://content.openalex.org/works/W4362489104.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362489333","https://openalex.org/W3023849184","https://openalex.org/W2986221179","https://openalex.org/W4410819457","https://openalex.org/W2972114226","https://openalex.org/W2947088251","https://openalex.org/W2889815745","https://openalex.org/W7127447446","https://openalex.org/W4415381368","https://openalex.org/W2996622009"],"abstract_inverted_index":{"Supplementary":[0],"Figure":[1],"1":[2,29],"Sensitivity":[3],"of":[4],"glioma":[5],"cell":[6],"lines":[7],"to":[8,14,32],"ABT-414.A.":[9],"The":[10],"cells":[11,23],"were":[12,24],"exposed":[13],"10":[15],"nM":[16],"ABT-414":[17,33],"for":[18,28],"72":[19],"h.B.":[20],"LN-229":[21],"EGFRvIII":[22],"pre-treated":[25],"with":[26],"AB806":[27],"h":[30],"prior":[31],"treatment.Metabolic":[34],"activity":[35],"was":[36],"assessed":[37],"by":[38],"MTT":[39],"assay":[40],"in":[41],"A":[42],"and":[43],"B.":[44]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}